Recursion Pharmaceuticals, Inc. RXRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Grant revenue | $171K+334% | $187K+434% | $192K— | $120K+823% | -$73K-124% | |
| Operating revenue | $6.3M-57.5% | $35.35M+684% | $4.98M-80.9% | $19.1M+32.6% | $14.82M+9.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Recursion Pharmaceuticals, Inc. break its business down?
- Recursion Pharmaceuticals, Inc. (RXRX) reports revenue from contract with customer, excluding assessed tax by product across 2 parts — Grant revenue and Operating revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Recursion Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Recursion Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.